181 related articles for article (PubMed ID: 34413700)
1. Establishment of an Academic Tissue Microarray Platform as a Tool for Soft Tissue Sarcoma Research.
Lee CJ; Wozniak A; Van Cann T; Timmermans I; Wellens J; Vanleeuw U; Briaire-de Bruijn IH; Britschgi C; Bovée JVMG; Zlobec I; Sciot R; Schöffski P
Sarcoma; 2021; 2021():6675260. PubMed ID: 34413700
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential.
Francis P; Namløs HM; Müller C; Edén P; Fernebro J; Berner JM; Bjerkehagen B; Akerman M; Bendahl PO; Isinger A; Rydholm A; Myklebost O; Nilbert M
BMC Genomics; 2007 Mar; 8():73. PubMed ID: 17359542
[TBL] [Abstract][Full Text] [Related]
3. Current molecular and therapeutic advances in liposarcoma, rhabdomyosarcoma, leiomyosarcoma, synovial sarcoma, and angiosarcoma.
Tanriverdi O; Yildiz A
J Oncol Pharm Pract; 2022 Apr; 28(3):635-645. PubMed ID: 35043739
[TBL] [Abstract][Full Text] [Related]
4. Soft tissue sarcoma subtypes exhibit distinct patterns of acquired uniparental disomy.
Tuna M; Ju Z; Amos CI; Mills GB
BMC Med Genomics; 2012 Dec; 5():60. PubMed ID: 23217126
[TBL] [Abstract][Full Text] [Related]
5. Can DNA Methylation Profiling Classify Histologic Subtypes and Grades in Soft Tissue Sarcoma?
Kim H; Joo MW; Yoon J; Park HS; Kim JH; Lee JH; Kim SH; Lee SK; Chung YG; Cho YJ
Clin Orthop Relat Res; 2024 Mar; 482(6):1028-37. PubMed ID: 38517415
[TBL] [Abstract][Full Text] [Related]
6. Establishment and Characterization of Histologically and Molecularly Stable Soft-tissue Sarcoma Xenograft Models for Biological Studies and Preclinical Drug Testing.
Cornillie J; Wozniak A; Li H; Wang Y; Boeckx B; Gebreyohannes YK; Wellens J; Vanleeuw U; Hompes D; Stas M; Sinnaeve F; Wafa H; Lambrechts D; Debiec-Rychter M; Sciot R; Schöffski P
Mol Cancer Ther; 2019 Jun; 18(6):1168-1178. PubMed ID: 30962320
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of trabectedin in advanced soft tissue sarcoma: beyond lipo- and leiomyosarcoma.
De Sanctis R; Marrari A; Marchetti S; Mussi C; Balzarini L; Lutman FR; Daolio P; Bastoni S; Bertuzzi AF; Quagliuolo V; Santoro A
Drug Des Devel Ther; 2015; 9():5785-91. PubMed ID: 26604682
[TBL] [Abstract][Full Text] [Related]
8. The PTEN Tumor Suppressor Gene in Soft Tissue Sarcoma.
Stefano S; Giovanni S
Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31416195
[TBL] [Abstract][Full Text] [Related]
9. Anaplastic lymphoma kinase protein expression, genetic abnormalities, and phosphorylation in soft tissue tumors: Phosphorylation is associated with recurrent metastasis.
Ishibashi Y; Miyoshi H; Hiraoka K; Arakawa F; Haraguchi T; Nakashima S; Hashiguchi T; Shoda T; Hamada T; Okawa T; Higuchi F; Shiba N; Nagata K; Ohshima K
Oncol Rep; 2015 Apr; 33(4):1667-74. PubMed ID: 25683346
[TBL] [Abstract][Full Text] [Related]
10. The rare primary bone sarcomas: imaging-pathological correlation.
Berkeley R; Andrei V; Saifuddin A
Skeletal Radiol; 2021 Aug; 50(8):1491-1511. PubMed ID: 33410967
[TBL] [Abstract][Full Text] [Related]
11. Sarcomas of the mediastinum with epithelioid morphology.
Perry KD; Montecalvo J; Perry AM
Mediastinum; 2021; 5():4. PubMed ID: 35118310
[TBL] [Abstract][Full Text] [Related]
12. T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas.
Pollack SM; He Q; Yearley JH; Emerson R; Vignali M; Zhang Y; Redman MW; Baker KK; Cooper S; Donahue B; Loggers ET; Cranmer LD; Spraker MB; Seo YD; Pillarisetty VG; Ricciotti RW; Hoch BL; McClanahan TK; Murphy E; Blumenschein WM; Townson SM; Benzeno S; Riddell SR; Jones RL
Cancer; 2017 Sep; 123(17):3291-3304. PubMed ID: 28463396
[TBL] [Abstract][Full Text] [Related]
13. Proteomic profiling of soft tissue sarcomas with SWATH mass spectrometry.
Milighetti M; Krasny L; Lee ATJ; Morani G; Szecsei C; Chen Y; Guljar N; McCarthy F; Wilding CP; Arthur A; Fisher C; Judson I; Thway K; Cheang MCU; Jones RL; Huang PH
J Proteomics; 2021 Jun; 241():104236. PubMed ID: 33895336
[TBL] [Abstract][Full Text] [Related]
14. Programmed Death Ligand 1 (PD-L1) Expression in Malignant Mesenchymal Tumors.
Kösemehmetoğlu K; Özoğul E; Babaoğlu B; Tezel GG; Gedikoğlu G
Turk Patoloji Derg; 2017; 1(1):192-197. PubMed ID: 28832074
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence in Situ Hybridization (FISH) for Differential Diagnosis of Soft Tissue Sarcomas.
Asif A; Mushtaq S; Hassan U; Akhtar N; Hussain M; Azam M; Qazi R
Asian Pac J Cancer Prev; 2018 Mar; 19(3):655-660. PubMed ID: 29580035
[TBL] [Abstract][Full Text] [Related]
16. Reassessment and clinicopathological prognostic factors of malignant fibrous histiocytoma of soft parts.
Oda Y; Tamiya S; Oshiro Y; Hachitanda Y; Kinukawa N; Iwamoto Y; Tsuneyoshi M
Pathol Int; 2002 Sep; 52(9):595-606. PubMed ID: 12406189
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of pazopanib monotherapy in patients who had been heavily pretreated for metastatic soft tissue sarcoma: a retrospective case series.
Yoo KH; Kim HS; Lee SJ; Park SH; Kim SJ; Kim SH; La Choi Y; Shin KH; Cho YJ; Lee J; Rha SY
BMC Cancer; 2015 Mar; 15():154. PubMed ID: 25885855
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical staining for KIT (CD117) in soft tissue sarcomas is very limited in distribution.
Hornick JL; Fletcher CD
Am J Clin Pathol; 2002 Feb; 117(2):188-93. PubMed ID: 11865845
[TBL] [Abstract][Full Text] [Related]
19. PML down-regulation in soft tissue sarcomas.
Vincenzi B; Perrone G; Santini D; Grosso F; Silletta M; Frezza A; Rossi S; Russo A; Rabitti C; Gebbia N; Badalamenti G; Casali P; Muda AO; Dei Tos AP; Tonini G
J Cell Physiol; 2010 Sep; 224(3):644-8. PubMed ID: 20578240
[TBL] [Abstract][Full Text] [Related]
20. Establishment and molecular characterisation of seven novel soft-tissue sarcoma cell lines.
Salawu A; Fernando M; Hughes D; Reed MW; Woll P; Greaves C; Day C; Alhajimohammed M; Sisley K
Br J Cancer; 2016 Oct; 115(9):1058-1068. PubMed ID: 27560552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
